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Objective: Loss of function of the astrocyte-specific protein MLC1 leads to the childhood-onset leukodystrophy
“megalencephalic leukoencephalopathy with subcortical cysts” (MLC). Studies on isolated cells show a role for MLC1
in astrocyte volume regulation and suggest that disturbed brain ion and water homeostasis is central to the disease.
Excitability of neuronal networks is particularly sensitive to ion and water homeostasis. In line with this, reports of
seizures and epilepsy in MLC patients exist. However, systematic assessment and mechanistic understanding of seiz-
ures in MLC are lacking.
Methods: We analyzed an MLC patient inventory to study occurrence of seizures in MLC. We used two distinct
genetic mouse models of MLC to further study epileptiform activity and seizure threshold through wireless extracellu-
lar field potential recordings. Whole-cell patch-clamp recordings and K1-sensitive electrode recordings in mouse
brain slices were used to explore the underlying mechanisms of epilepsy in MLC.
Results: An early onset of seizures is common in MLC. Similarly, in MLC mice, we uncovered spontaneous epilepti-
form brain activity and a lowered threshold for induced seizures. At the cellular level, we found that although passive
and active properties of individual pyramidal neurons are unchanged, extracellular K1 dynamics and neuronal net-
work activity are abnormal in MLC mice.
Interpretation: Disturbed astrocyte regulation of ion and water homeostasis in MLC causes hyperexcitability of neu-
ronal networks and seizures. These findings suggest a role for defective astrocyte volume regulation in epilepsy.
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“Megalencephalic leukoencephalopathy with sub-cortical cysts” (MLC; MIM 604004) is a rare
childhood-onset leukodystrophy,1,2 caused by homozy-
gous recessive mutations in MLC13 or GLIALCAM.4
MLC1 is a membrane protein almost exclusively
expressed in brain astrocytes.5 GlialCAM is a chaperone
of MLC1, ensuring its localization in the membrane of
astrocyte endfeet.4,6,7 Patients show very high water
content in the brain white matter. Biopsies reveal count-
less fluid-filled vacuoles within the outer lamellae of mye-
lin sheaths and, to a lesser degree, in perivascular
astrocyte endfeet.8 Mutations affecting MLC1 protein
negatively impact volume-regulated anion channel
(VRAC) activity in astrocytes, leading to impaired regu-
latory volume decrease9 and resulting in chronically swol-
len astrocytes.10
Because the pathophysiology of MLC has mainly
been studied in isolated cells, consequences of astrocyte
dysfunction for neuronal network functioning are
unknown. The disease is characterized by infantile-onset
macrocephaly, slow deterioration of motor functions, and
later cognitive decline. Minor head trauma can lead to
temporary worsening, often with seizures, prolonged
unconsciousness, and motor deterioration.11 Mild epi-
lepsy, which typically responds well to treatment, has
been described in many MLC patients, but status epilep-
ticus has also been described.12 Occurrence of epilepsy
has not been studied in a large cohort of genetically con-
firmed patients, and its cellular basis is not understood.
The panglial syncytium, the glial network consist-
ing of gap-junction coupled astrocytes and oligodendro-
cytes, is essential for the uptake and dispersal of
extracellular K1 ([K1]o) released from neurons during
periods of high neuronal activity.13,14 Disruption of pro-
teins important for this process, such as Kir4.1 K1 chan-
nels,15,16 glial gap-junction proteins,17 and the astrocytic
water channel aquaporin-4 (AQP4),18 lead to impaired
[K1]o clearance and to epileptiform brain activity or an
altered seizure threshold. MLC1 and GlialCAM undergo
molecular interactions with several of these proteins.19,20
Therefore, we hypothesize that defective astrocyte volume
regulation in MLC leads to impaired control of [K1]o,
8
resulting in hyperexcitability of neuronal networks and
epilepsy.
We recently developed an Mlc1-null mouse recapit-
ulating major pathological features of MLC.10 Addition-
ally, Glialcam-null mice21 show similar pathological
features.7,22 Mlc1- and Glialcam-null mice (collectively
referred to here as MLC mice) are excellent tools to
investigate the pathophysiology of MLC. Here, we com-
bine a clinical inventory of MLC patients with in vivo
and in vitro electrophysiology in MLC mice to study the
cellular pathophysiology of epilepsy in MLC. We con-
firm that early seizure onset is common in MLC
patients. Similarly, MLC mice show spontaneous epilep-
tiform activity and a reduced threshold for seizure induc-
tion. At the cellular level, we find that excitability of
single neurons is unchanged, whereas stimulation-
induced increases in [K1]o and network excitability are
increased. Taken together, we demonstrate that loss of
function of the astrocytic protein MLC1 disturbs neuro-




Experimental procedures involving mice were in strict compli-
ance with animal welfare policies of the Dutch government and
were approved by the Institutional Animal Care and Use Com-
mittee of the VU University, Amsterdam. The clinical inventory
was approved by the Medical Ethics Committee of the VU
University Medical Center.
MLC Patients
We executed a cross-sectional observational study among 205
genetically proven patients with autosomal-recessive MLC pre-
sent in the Amsterdam Leukodystrophy database, containing
patients referred to the VUmc Center for Childhood White
Matter Disorders for genetic testing. As part of a larger study
on the clinical phenotype of MLC,23 standardized clinical ques-
tionnaires including items on epilepsy were completed primarily
by the patient’s physician. If this source was unavailable, infor-
mation was derived from medical records, supplemented by
information provided by families.
Mice
Transgenic mice and their wild-type littermates had a C57BL/
6J background. Generation of both Mlc1 deficient mice (Mlc1-
null)10 and Glialcam deficient mice (Glialcam-null)21,22 was
previously described. Null animals were compared with wild-
type littermate controls, with the exception of extracellular field
potential/seizure threshold recordings. Here, littermate data for
both MLC lines were grouped because no differences between
littermates were observed.
Behavioral Assays
In vivo experiments were performed on adult (8–12 months
old) mice. Forty-eight-hour recordings of basal activity were
performed on both male and female mice. Kainate-induced
seizures were only studied in male mice because sex strongly
influences sensitivity to kainate.24 To score hindlimb clasping,
each mouse was suspended for 30 seconds by its tail and kept
10cm above a stable platform. Seizure threshold and severity
were assessed using an intraperitoneal injection of kainate
(kainic acid; 10mg/kg). Behavioral response was scored using a
revised Racine’s seizure scale.25 Maximal score during
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subsequent 10-minute time bins was assessed by a trained
observer unaware of genotype. Mice were sacrificed if seizure
severity reached score 5c.
Telemetric Extracellular Field Potential
Recordings
Electrocorticogram (ECoG) recordings and hippocampal local
field potential (LFP) recordings were performed with wireless
ETA-F10 transmitters (Data Science International, St. Paul,
MN). For electrode placement, animals were anesthetized with
isoflurane (induction 3%, flow rate 0.8l/min; maintenance 1.5–
1.8%, flow rate 0.6l/min). For ECoG recordings, a recording
electrode (stereotaxic coordinates relative to bregma: 2.22mm
anterior and 1mm lateral, corresponding to motor cortex) was
implanted subdurally through a small hole drilled in the skull
and held in place with a screw (A2-70; Jeveka, Almere-Poort, The
Netherlands) made of stainless steel. For hippocampal LFP
recordings, an insulated depth-electrode (W-electrode; Open
Source Instruments, Watertown, MA) was lowered into the brain
(stereotaxic coordinates relative to bregma: 2.2mm posterior,
2.0mm lateral, 1.7mm depth, corresponding to the CA1 region
of hippocampus). A ground electrode was placed subdurally
6mm posterior and 1mm lateral relative to bregma. All electrodes
were sealed with dental cement. The calibrated transmitter was
placed subcutaneously along the dorsal flank of the animal. Mice
received analgesia (Temgesic; 0.1mg/kg subcutaneously) before
surgery and recovered for 7 days before recordings.
ECoG/LFP signal was collected through a radiofrequency
receiver (RLA1020; Data Science International) and analog out-
put adapter (Option RO8, Data Science International) using
Powerlab 4/10 (AD-Instruments, Austin, TX; sampling: 1kHz;
filtering: 200Hz low pass). Infrequent periods of severe electrical
noise were manually removed from the recording before further
analysis. Recordings were analyzed using the Neuroarchiver tool
(Open Source Instruments; http://www.opensourceinstruments.
com/Electronics/A3018/Seizure_Detection.html). For more
details on analysis, see the website or publication.26 In brief, data
were split into 1-second epochs. A power threshold was set (5
times baseline power), and putative events were epochs in which
this threshold was crossed. Values of six metrices (power (in the
0–200Hz band), coastline, voltage asymmetry, coherence, inter-
mittency, and rhythm) were determined for each putative event,
and these were compared with a library of events manually classi-
fied as seizure-like. Events were classified according to their
Euclidian distance to events in a manually constructed event
library. The library was constructed by an operator who classified
events as “no event/baseline” (no obvious electrographic or
behavioral event), “interictal event,” or “artifact” (grooming
related noise or antenna glitches). In recordings from kainate-
injected animals, additional event types appeared: large single
negative peak spike waves (simple spike-waves; SS); spike waves
having one or more shoulders (complex spike-waves; CS); and
runs of intermediate frequency (IF) discharges (5–12Hz) lasting
0.2 to 12 seconds with typically smaller amplitude (Fig 4B and
Supplementary Movie 1). Following library construction, all data
were analyzed without further manual interference.
Slice Preparation
Acute brain slices were prepared from 3- to 5-month-old mice.
After decapitation, the brain was removed in ice-cold solution
containing (mM): 70 sucrose, 70 NaCl, 25 D-glucose, 25
NaHCO3, 2.5 KCl, 1.25 NaH2PO4*H2O, 5.0 MgSO4*H2O, 1
CaCl2, 3 sodium pyruvate, and 1 sodium ascorbate (carboxy-
genated with 5%CO2/95%O2, 300–310mOsm). Coronal hip-
pocampal slices (350 mm) were cut on a microtome (Thermo
Fisher Scientific, Waltham, MA), kept in slicing solution at
32 C for 20 minutes, followed by 20-minute recovery at room
temperature. Afterward, slices were stored for >1 hour at room
temperature in ACSF containing (mM): 125 NaCl, 3 KCl, 1.2
NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose
(carboxygenated with 5%CO2/95%O2, 300–305mOsm).
Patch-Clamp Recording
Slices were transferred to the setup and perfused with ACSF
(5ml/min at 30–31 C). Recording ACSF contained CNQX
(10mM), AP-5 (50 mM), and Gabazine (3 mM). Patch pipettes
(3–5MX) were filled with intracellular solution containing
(mM): 111 K-gluconate, 8 KCl, 10 HEPES, 4Mg-ATP, 0.4
Na-GTP, 10 K-phosphocreatine, 0.2 EGTA, and 0.37% biocy-
tin (7.4 pH; 2906 10mOsm). Recordings were made using an
Axopatch 700B amplifier and Clampex software (sampling:
50kHz; filtering: 30kHz; Axon Instruments, Union City, CA).
After determination of resting membrane potential, cells were
kept in current clamp at –65mV through steady current injec-
tion. Data were analyzed using a custom-written script in Mat-
lab (version R2012a; The MathWorks, Inc., Natick, MA).
Action potentials (APs) were required to exceed a membrane
potential threshold of –20mV and a speed threshold of 10mV/
ms to be included in analysis. AP threshold was defined by
determining the peak of the AP derivative, and measuring the
membrane potential at which 10% of this maximum was
reached. AP half-width was calculated as the time difference
between the two time points corresponding to 50% of the AP
amplitude (AP peak/AP threshold). For most neurons, pyrami-
dal identity was confirmed after recording by biocytin staining,
using the avidin-biotin-peroxidase method.27
K1-Sensitive Electrode Recordings
K1-sensitive microelectrodes were prepared from thin walled
nonfilamented glass capillaries (GC150T-10; Harvard Appara-
tus, Holliston, MA) pulled to a tip inner diameter in the range
of 2 lm.28 Microelectrodes were silanized with gaseous N,N-
dimethyltrimethylsilylamine (41716; Sigma-Aldrich, St. Louis,
MO) at 200 C for 8 to 10 hours before being filled with a
short column (120–150lm) of liquid membrane solution
(99373, K1 Ionophore I Cocktail B; Sigma-Aldrich) and
150mM of NaCl, 3mM of KCl as backfilling solution (150–
180MX). Tips of a K1-sensitive and a field-potential electrode
(2MX, filled with 150mM of NaCl, 3mM of KCl) were placed
5 lm (62 lm) from each other. Voltage signal from both
channels to the same reference electrode were recorded using a
MultiClamp 700B double amplifier (Axon Instruments), and
differential voltage between the two electrodes was calculated by
ANNALS of Neurology
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subtraction. K1-sensitive electrodes were calibrated before and
after the experiment (calibration solutions: 3, 6, 12, 24, or
48mM of KCl, 150mM of NaCl). Data obtained with a K1-
sensitive electrode were excluded when calibrations before and
after differed by more than 2.5mV for 3, 6, or 12mM of KCl.
For recording [K1]o dynamics in hippocampus, both K
1-
sensitive electrode and field-potential electrode were placed in
CA1 stratum radiatum (depth 80–100 lm). A concentric bipo-
lar stimulation electrode was placed 550 to 600lm lateral from
the recording site onto stratum radiatum. Input-output curves
were constructed by recording field excitatory postsynaptic poten-
tials (fEPSPs) following single stimulation pulses of increasing
strength (0–950lA; 50-lA steps). Trains of 10-second stimula-
tion at 5, 10, or 20Hz, 450 lA, were applied twice and the aver-
aged response parameters were calculated. Subsequently,
recording electrodes were moved into stratum pyramidale (stimu-
lation electrode remained in the same location). Data were ana-
lyzed using custom-written procedures in IGOR-pro
(Wavemetrics, Lake Oswego, OR). Population spike area in stra-
tum pyramidale was defined as the area between large negative
deflections in the measured fEPSP and a fitted diagonal connect-
ing the two neighboring local maxima (Fig. 8B; shaded area).
Statistical Analysis
Statistical analysis was performed with Prism (version 7; Graph-
Pad Software Inc., La Jolla, CA). For behavioral and ECoG
recordings, nonparametric analysis of variance (ANOVA; Krus-
kal-Wallis), followed by Dunn’s multiple comparisons (wild-
type versus Mlc1-null and Glialcam-null) was performed. For
patch-clamp data and basal [K1]o, parameters, we tested for
normality using the Shapiro-Wilk test. Data were compared
using regular t test or, in case of deviant normal distribution,
Mann–Whitney U test. For input-output analysis and analysis
of stimulation-induced [K1]o, two-way ANOVA followed by
Sidak’s multiple comparison test was performed. Kaplan-Meier
survival curves were compared using log-rank statistics.
Results
Clinical Seizures in MLC Patients
Information on seizure characteristics was obtained
from 141 patients with recessive MLC1 mutations and
17 patients with recessive GLIALCAM mutations (137
families; Supplementary Table 1). Survival analysis
showed that 75.8% of patients with MLC1 mutations
and 73.4% of patients with GLIALCAM mutations
experienced at least one seizure before 25 years of age
(Fig 1A,B). Curves were not different for patients with
an MLC1 defect and patients with a GLIALCAM
defect.
Of all patients with seizures, 13% had experienced
only one seizure at the time of clinical inventory, often
provoked by mild head trauma (8 of 12 patients) or by
febrile illness (2 of 12 patients). Seventy-three percent
had epilepsy that was well controlled with medication.
Of all patients 6 years of age, 63% met the Interna-
tional League against Epilepsy criteria for epilepsy.29
Clinically, generalized tonic-clonic seizures and focal
seizures (sometimes with impaired awareness and/or
focal to bilateral tonic-clonic seizures) were most com-
mon. Mild head trauma was an important provoking
factor, causing one or more seizures in 55% of patients
with seizures. One or more status epilepticus had
occurred in 17%, of which most (58%) occurred for
the first time a few years after the first seizure. 6 of the
158 patients were deceased. Of these 6, 3 deaths were
related to epilepsy.
Taken together, the patient inventory shows that an
early onset of epileptic seizures is an integral part of the
MLC phenotype. Mild head trauma is an important pro-
voking factor and status epilepticus occurs relatively fre-
quently and early in the disease.
Hindlimb Clasping and Spontaneous Interictal
Activity in MLC Mice
To understand the cellular pathophysiology of epilepsy in
MLC, we studied two MLC mouse models: the Mlc1-
null mouse and the Glialcam-null mouse. Previous auto-
mated behavioral analysis of Mlc1-null mice did not
uncover behavioral abnormalities.10 For Glialcam-null
FIGURE 1: Early-onset seizures are often observed in MLC patients. (A) Survival analysis (Kaplan-Meier) of the proportion of patients
that are seizure free as a function of age for patients with homozygous recessiveMLC1 or (B)GLIALCAMmutations. Censored patients
(seizure free at last follow-up) are indicated by vertical lines. Ninety-five percent confidence intervals are depicted by shaded areas.
Survival curves were not different for patients with an MLC1 defect and patients with a GLIALCAM defect (log-rank test: p50.56).
Median age at the occurrence of the first seizure was 3 years, mode 2 years (range from first year of life up to 56 years). MLC5mega-
lencephalic leukoencephalopathy with subcortical cysts. [Color figure can be viewed at www.annalsofneurology.org]
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mice, behavioral analysis has not been reported. We
observed that both Mlc1-null and Glialcam-null mice
showed hindlimb clasping when suspended from the tail
(Fig 2). This is a sign of neurological abnormality, co-
occurring with seizures or increased seizure susceptibility
in several mouse models for neurological diseases.30,31
To test whether abnormal electrical activity is present
in brains of MLC mice, we performed wireless ECoG
recordings with an electrode placed above the motor cortex
in both MLC mouse models (Fig 3A). Long-term record-
ings (48 hours) from mice in their home cage revealed that
both MLC lines show a significantly higher occurrence of
abnormal discharges than wild-type mice (Fig 3B–E).
These discharges bear resemblance to interictal spikes.32
They did not have a clear behavioral correlate, as assessed
from simultaneous video recordings of mouse behavior.
To assess whether interictal spikes also occurred in
the hippocampus, we performed wireless LFP recordings
with a depth-electrode placed in the hippocampal CA1
area. Similar to what we observed in motor cortex, MLC
mice showed a significantly higher occurrence of interic-
tal discharges compared to wild-type mice (wild-type:
15.76 7.1 events/day, n5 3; MLC: 331.26 95.9 events/
day, n5 3 Glialcam-null and 1 Mlc1-null; p5 0.039).
Taken together, MLC mice show an overt hindlimb
clasping phenotype. Although major behavioral seizures
did not occur during our recording sessions, and were
not observed during previous phenotyping,10 unprovoked
interictal spikes are present in MLC mice.
Lowered Seizure Threshold and Increased
Seizure Severity in MLC Mice
The presence of unprovoked interictal spikes in MLC
mice suggests that they might be more sensitive to
evoked seizure activity. To test this, mice received a single
intraperitoneal injection with the chemoconvulsant
kainate, at a dose which does not induce severe seizures
in C57BL/6J mice (10mg/kg),33 followed by ECoG
recording and behavioral scoring using the modified
Racine score.25 While wild-type mice only reached
Racine score 2 or 3, with time Mlc1-null and Glialcam-
null mice developed more severe seizures with multiple
generalized tonic-clonic seizure events (Racine score 5a–
5c; Fig 4A).
Analysis of ECoG recordings following kainate injec-
tion revealed three main types of epileptic events: spike-
wave complexes either with a single negative peak (SS) or
featuring one or more shoulders (CS), interspersed with
runs of intermediate frequency (IF) discharges (5–12Hz)
lasting 0.2 to 12 seconds, which typically had a small ampli-
tude (Fig 4B). IF discharges correlated with severe motor
seizures (Supplementary Movie 1), in line with previous
data.34 In the 60-minute period following kainate injection,
wild-type mice showed few simple SS and CS events, with
very rare IF discharges (Fig 4C–E). In contrast, both Mlc1-
null and Glialcam-null mice showed a significantly higher
number of IF discharges than wild-type animals (Fig 4E).
No significant differences were observed in the occurrence
of SS and CS events, although a trend toward more events
in MLC mice was present. Taken together, these findings
highlight that MLC mice have a lower threshold for kainate
induced seizures than wild-type mice.
Neuronal Excitability in MLC Mice
Spontaneous interictal activity in motor cortex and hip-
pocampus and a lowered threshold for evoked seizures
suggest neuronal hyperexcitability in MLC mice. To test
whether this was alternatively to increased intrinsic neu-
ronal excitability, we performed whole-cell patch-clamp
recordings from CA1 pyramidal neurons in acute hippo-
campal brain slices (Fig 5 and Supplementary Table 2).
Passive electrophysiological properties (membrane potential,
FIGURE 2: Hindlimb clasping in MLC mice. (A) Representative pictures illustrating the hindlimb clasping phenotype. Scoring was
as follows: 0: normal (hindlimbs fully spread and moving); 1: intermediate (intermittent clasping of one hindlimb); 2: full (both
hindlimbs fully drawn up to the abdomen). Left: wildtype, scored 0; middle, right: Mlc1-null and Glialcam-null mice respectively,
both scored 2. (B) Both Mlc1-null (n512) and Glialcam-null (n58) mice exhibited significantly increased hindlimb clasping sever-
ity compared to the wild-type controls (n514; p50.0003; wild-type vs Mlc1-null, p50.0003; wild-type vs Glialcam-null,
p50.014). Open circles show individual mice. Bars indicate mean6SEM. *p<0.05; **p<0.01; ***p<0.001. MLC5megalence-
phalic leukoencephalopathy with subcortical cysts. [Color figure can be viewed at www.annalsofneurology.org]
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input resistance) did not differ between MLC mice and their
wild-type littermates (Fig 5D,E). Furthermore, AP wave-
forms were indistinguishable betweenMlc1-null mice and lit-
termate controls (Fig 5C,D). Glialcam-null mice also showed
similar AP waveform properties as their wild-type littermates,
apart from a slight increase in AP peak and half-width (Fig
5E). Importantly, input-output characteristics and maximal
firing frequency were identical in both MLC mouse lines
compared to their wild-type littermate controls (Fig 5F,G).
We hypothesized that stimulating single neurons to
fire APs for a prolonged period might uncover more sub-
tle differences in intrinsic properties. Sustained AP firing
was evoked by applying prolonged current injections
with step-wise increments (Fig 6A). Prolonged stimula-
tion altered the AP waveform (Fig 6B), but again this
did not differ between MLC mice and their wild-type lit-
termate controls (Fig 6C–E).
To check whether intrinsic neuronal properties in
other brain regions are similarly unaffected in MLC mice,
we performed an additional set of patch-clamp recordings
from layer 5 pyramidal neurons in primary motor cortex
(M1). Like in hippocampus, we observed no differences in
passive and active neuronal properties, nor in responses to
prolonged current injections, that could explain hyperex-
citability in MLC mice (data not shown).
Taken together, these results show that intrinsic excit-
ability of principal neurons in hippocampus and neocortex is
largely unchanged in MLC mice, and cannot account for the
observed interictal activity and decreased seizure threshold.
Increased Stimulation-Induced [K1]o Around
CA1 Synapses of MLC Mice
Impaired astrocyte functioning can lead to disturbed [K1]o
dynamics. Therefore, we measured [K1]o dynamics using
FIGURE 3: Spontaneous interictal activity in MLC mice. (A) Schematic representation of the implanted electrode for wireless ECoG
recording. (B) X-ray image of a mouse showing subcutaneous placement of the radiotransmitter (bar55mm). (C) Top: representative
example 12-minute ECoG recording from aMlc1-null mouse. Bottom: Expanded display of 100 seconds from the top trace. Right, boxed:
Further expansion (10 seconds) of the boxed region. (D) Same as (C), but for aGlialcam-null mouse. (E) Same as (B,C), but for a wild-type
mouse. (F) Bar graph showing the number of interictal spikes per day for all three groups. Open circles indicate individual mice, bars show
average6SEM. Both MLC mouse lines had a significant increase in interictal spikes (wildtype: 51.865.3 events/day, n515; Mlc1-null:
465.1686.8 events/day, n514;Glialcam-null: 361.5689.0, n512; p50.0001; wildtype vsMlc1-null, p<0.0001; wildtype vsGlialcam-
null, p50.0027). *p<0.05; **p<0.01; ***p<0.001. ECoG5electrocorticogram;MLC5megalencephalic leukoencephalopathywith sub-
cortical cysts.
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FIGURE 4: Lowered seizure threshold in MLC mice. (A) Behavioral scoring of seizure activity over time in wild-type (blue) and
MLC mice (Mlc1-null: red; Glialcam-null: green; thin lines show individual mouse responses; thick lines show averages) following
kainate injection (10mg/kg intraperitoneally). For each 10-minute interval, the highest level of epileptic activity was scored
using the modified Racine seizure scale. The bar graph shows maximum Racine score during 60-minute trial (open circles indi-
cate individual mice, bars show average). MLC mice reached significantly higher behavioral seizure scores (wildtype: n58;
Mlc1-null: n58; Glialcam-null: n57; p50.0014; wildtype vs Mlc1-null, p50.0060; wildtype vs Glialcam-null, p50.0023). (B)
Top: Morlet-wavelet ECoG spectra from kainate-injected mice. Bottom: ECoG traces showing simple spike waves (SS), complex
spike waves (CS) and runs of intermediate frequency (IF) discharges (expanded below). (C–E) Temporal progression of kainate-
induced SS, CS, and IF events, respectively. Bar graphs show total number of SS, CS, and IF events in 60-minute trial. A signifi-
cantly higher number of IF discharges was observed in MLC mice (wildtype: 4.162.9 discharges/h; Mlc1-null: 39.0624.8; Glial-
cam-null: 35.4615.8; p50.0101; wildtype vs Mlc1-null, p50.028; wildtype vs Glialcam-null, p50.012). Error bars and shaded
regions indicate SEM. *p<0.05; **p<0.01; ***p<0.001. ECoG5electrocorticogram; MLC5megalencephalic leukoencephalop-
athy with subcortical cysts.
ANNALS of Neurology
642 Volume 83, No. 3
calibrated K1-sensitive electrodes28 in acute brain slices of
hippocampal CA1 area (stratum radiatum; Fig 7A). We did
not observe differences in basal [K1]o between MLC mice
and wild-type littermates at rest (Fig 7B).
Next, we simultaneously recorded [K1]o and field
potential responses in stratum radiatum upon extracellu-
lar stimulation of Schaffer collaterals (Fig 7A). First, we
determined the input-output curve of the fEPSP
FIGURE 5: Intrinsic properties of CA1 pyramidal neurons are unaltered in MLC mice. (A) Schematic drawing of the hippocam-
pus showing the patch-clamp electrode at the region of recording (CA1). (B) Representative AP firing pattern of a wild type
(blue) and an Mlc1-null (red) pyramidal neuron upon 200-, 300-, 400-, and 600-pA current injection. (C) Top: AP waveform of
the first AP fired by single cells (thin lines) and the average AP waveform per genotype (thick lines). Bottom: AP phase plane
plot of the first AP fired by single cells. Data of Mlc1-null (red) and wild-type littermates (blue) are shown on the left and data
of Glialcam-null (green) and wild-type littermates (blue) on the right. (D) Active properties (first three panels; threshold, AP
peak, and half-width) and passive properties (last three panels; input resistance [Rin], resting membrane potential [RMP], and
rheobase) for wild-type (blue) and Mlc1-null mice (red) and (E) for wild-type (blue) and Glialcam-null mice (green). AP properties
were derived from the first AP fired by a cell. For mean values and statistics, see Supplementary Table 2. (F) Input-output
curve showing AP firing frequency vs stimulation current (left) and scatter plot showing maximum firing frequency (right) for
wild-type (blue) and Mlc1-null (red) pyramidal neurons and (G) for wild-type (blue) and Glialcam-null (green) pyramidal neurons.
Input-output curve was determined using 800-ms-long step current injections (25-pA steps from –100 to 625pA). No significant
differences were observed in input-output curves (wildtype vs Mlc1-null: p50.74; wildtype vs Glialcam-null: p50.39). Error
bars and shaded regions indicate SEM. **p<0.01; ***p<0.001. AP5action potential; MLC5megalencephalic leukoencephal-
opathy with subcortical cysts.
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amplitude by single stimulations with step-wise increases
in stimulation strength. Notably, no genotype differences
were observed in input-output curves, showing that basal
synaptic strength of the Schaffer collaterals is unchanged
in MLC mice (Fig 7C).
Increases in [K1]o were induced by sustained repet-
itive Schaffer collateral stimulation at a fixed stimulation
strength for 10 seconds, either at 5, 10, or 20Hz. A stim-
ulation frequency-dependent increase in [K1]o was
observed in all experiments (Fig 7D,E). However, signifi-
cantly higher stimulation-induced increases in [K1]o
were measured both in Mlc1-null (Fig 7F) and in Glial-
cam-null mice (Fig 7G). In contrast, the sum of all
fEPSP amplitudes measured during repetitive stimulation
was not different between genotypes (Fig 7F,G).
Observed differences in peak [K1]o were stimulation
frequency-dependent, with 20-Hz stimulation showing
the strongest increase in peak [K1]o (Fig 7F,G). Despite
the fact that MLC mice showed a significantly higher
increase in [K1]o during the stimulation, the poststimu-
lation [K1]o recovery (80–20% decay time) was not dif-
ferent between MLC mice and wild-type littermates
(data not shown).
These findings show that while the strength and
efficacy of Schaffer collateral synapses are unchanged in
MLC, prolonged high-frequency stimulation of these
synapses leads to a larger increase in [K1]o in MLC mice
than in wild-type littermates.
Increased Network Excitability in CA1 Somatic
Layer of MLC Mice
Increased [K1]o in the dendritic layer upon repetitive
stimulation could lead to stronger and more sustained
depolarization of the dendritic tree and may therefore
result in increased network excitability. After finishing
recording in stratum radiatum, we moved recording elec-
trodes into the CA1 cell body layer (stratum pyramidale)
while keeping the stimulation electrode at the same posi-
tion (Fig 8A). When determining the input-output curve
in stratum pyramidale with single stimulations, both
MLC mice showed a trend toward an increase in popula-
tion spikes (pop-spikes; Fig 8B), although this did not
reach significance (Fig 8B,C). Similar to what was
observed in stratum radiatum, prolonged Schaffer collat-
eral stimulation led to larger increases in [K1]o in both
MLC mice than in wild-type littermates (Fig 8C). Also
similar to stratum radiatum, the increase in [K1]o was
frequency dependent (Fig 8F,G). Strikingly, the sum of
all pop-spike areas evoked during the train stimulation
was also increased in both MLC mouse models (Fig 8C),
indicating increased network excitability in MLC mice
(Fig 8F, G). Similar to what we observed in stratum radi-
atum, the poststimulation [K1]o recovery (80–20% decay
time) in stratum pyramidale was not different between
MLC mice and wild-type littermates (data not shown).
In conclusion, [K1]o recordings show that, while
Schaffer collateral input strength is unchanged,
FIGURE 6: Prolonged stimulation leads to similar action potential (AP) firing in MLC mice and wild-type littermates. (A) Repre-
sentative firing response trace of a CA1 neuron during prolonged stimulation. Prolonged stimulation consisted of eight 20-
second long steps with an increment of one half rheobase (rheobase: current at which an AP was first observed). (B) Represen-
tative phase plane plots showing the first derivative (V s–1) versus membrane voltage (mV) for representative wild-type (blue,
left) and Mlc1-null (red, right) neurons. Each line represents the first AP from a 20-second current step, with the earliest AP as
darkest color and latest AP as lightest color. (C–E) Input-output curves showing the average firing frequency (C), average half-
width (D), and average AP peak (E) per 20-second current step vs stimulation current (represented as multiplications of the
rheobase). Left panels show data of Mlc1-null mice (red) and wild-type littermates (blue) and right panels show data of Glial-
cam-null mice (green) and wild-type littermates (blue). No significant differences between MLC mice and littermate controls
were observed for any of these parameters (wildtype vs Mlc1-null: p50.55 [frequency], p50.95 [half-width], and p50.71
[absolute peak]; wildtype vs Glialcam-null: p50.26 [frequency], p50.30 [half-width], and p50.83 [absolute peak]). Shaded
regions indicate SEM. AP5 action potential; MLC5megalencephalic leukoencephalopathy with subcortical cysts.
ANNALS of Neurology
644 Volume 83, No. 3
prolonged synaptic stimulation leads to higher rises in
[K1]o in CA1, both in stratum radiatum and in stra-
tum pyramidale. Furthermore, there is an increase in
stimulation-induced pop-spikes in CA1, suggesting
increased excitability of neuronal networks in MLC
mice.
FIGURE 7: Larger stimulation-induced rises in [K1]o in CA1 stratum radiatum of MLC mice. (A) Schematic drawing of the hippo-
campus showing recording and stimulating electrodes. (B) Basal [K1]o in stratum radiatum (wildtype [blue]: 3.060.06mM;
n510 vs Mlc1-null [red]: 3.160.04; n510; p50.63; wildtype [blue]: 3.160.08; n511 vs Glialcam-null [green]: 3.160.10;
n511; p>0.99). (C) Input-output curve showing fEPSP amplitude vs stimulation current. Curves did not differ between MLC
mice and littermate controls (wildtype vs Mlc1-null: p50.47; wildtype vs Glialcam-null: p50.14) (D,E) Top: averaged trace of
[K1]o upon 10-second stimulation (gray area) at 5, 10, and 20Hz. Bottom: averaged fEPSP amplitude for each stimulation pulse
during 5, 10, and 20Hz stimulation. (F,G) Significant stimulation frequency-dependent increase in [K1]o in MLC mice (wildtype
vs Mlc1-null: p50.034; wildtype vs Glialcam-null: p50.013) with no significant change in fEPSP amplitude sum (wildtype vs
Mlc1-null: p50.087; wildtype vs Glialcam-null: p50.29). Thin lines show individual experiment. Error bars and shaded regions
indicate SEM. *p<0.05; **p<0.01. MLC5megalencephalic leukoencephalopathy with subcortical cysts.
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FIGURE 8: Increased stimulation-induced [K1]o rises and network excitability in CA1 stratum pyramidale of MLC mice. (A) Sche-
matic drawing of the hippocampus showing recording and stimulating electrodes. (B) Representative field recording upon sin-
gle Schaffer collateral stimulation (450mA) in a wildtype mouse (blue) and an Mlc1-null mouse (red). The pop-spike area was
defined as the shaded region in the traces. (C) Pop-spike area versus stimulation current. Although a trend towards larger pop-
spike area was observed this did not reach significance (wildtype [blue; n510] vs Mlc1-null [red; n510]: p50.053; wildtype
[blue; n511] vs Glialcam-null [green; n511]: p50.076). (D,E) Top: averaged trace of [K1]o upon 10-second stimulation (gray
area) at 5, 10, and 20Hz. Bottom: averaged pop-spike area for each stimulation pulse during 5, 10, and 20Hz stimulation. (F,G)
Significant stimulation frequency dependent increase in [K1]o in MLC mice (wildtype vs Mlc1-null: p50.021; wildtype vs Glial-
cam-null: p50.035). Total summed pop-spike area was also significantly increased in MLC mice (wildtype vs Mlc1-null:
p50.015; wildtype vs Glialcam-null: p50.033). Thin lines show individual experiment. Error bars and shaded regions indicate
SEM. *p<0.05; **p<0.01. MLC5megalencephalic leukoencephalopathy with subcortical cysts.
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Discussion
We have shown that an early onset of epileptic seizures is
common in MLC patients. We studied the cellular patho-
physiology of seizures in two different genetic mouse
models for MLC. Both Mlc1-null and Glialcam-null mice
show hindlimb clasping, unprovoked interictal brain activ-
ity, and a lowered threshold for kainate-induced seizures.
While intrinsic excitability of principal neurons is
unchanged in MLC mice, increases in [K1]o upon net-
work activation and network excitability are higher in
both MLC mouse models. Thus, astrocyte dysfunction in
MLC leads to disturbed [K1]o dynamics and network
hyperexcitability, and lowers the threshold for seizures.
Seizures in MLC Patients and MLC Mouse
Models
This is the first report on seizure characteristics in a large
cohort of genetically confirmed patients with recessive
MLC. An estimated 75% of all MLC patients experien-
ces at least one seizure and 63% of patients older than 6
years has been diagnosed with epilepsy, which is in line
with previous reports,12,35 and confirms that epilepsy is
common in MLC. Epilepsy in MLC patients is mostly
well controlled with medication compared to the general
epilepsy population (only 14% had moderately to poorly
controlled epilepsy versus 20–30% of general epilepsy
patients).36,37 However, occurrence of status epilepticus is
high (17%) compared to the overall occurrence
reported for children and adults with epilepsy during
follow-up (10%),38,39 indicating that once seizures are
initiated, restoring neuronal network activity to its nor-
mal state is hampered in MLC.
A striking feature of MLC is the high susceptibility
to develop seizures immediately following mild head
injury (54% of patients with seizures). In patients with
epilepsy in general, mild head trauma is only rarely
reported as a seizure-precipitating factor.40 Interestingly,
animal studies show that closed head injury leads to a
rise in brain [K1]o.
41 The high sensitivity to mild head
injury of MLC patients could therefore reflect an
increased sensitivity to rises in [K1]o, which would be in
line with our observations in mouse models for MLC
(see below).
Our results in Mlc1-null and Glialcam-null mice
confirm that epileptiform brain activity and a lowered
seizure threshold are an integral part of MLC. However,
because overt spontaneous behavioral seizures are absent
in both mouse models for MLC, the phenotype of MLC
mice is milder than that of MLC patients. This discrep-
ancy between MLC mice and patients has been discussed
before10 and might be related to different compensation
by mice to loss of MLC1 function compared to humans.
Another likely contributing factor is the much shorter
life-span of mice than that of humans, given that MLC
patients develop major neurological dysfunction only
after a delay of several years to decades.1,8
Cellular Basis of Epilepsy in MLC
The use of mouse models allowed us to investigate the
cellular basis of epilepsy in MLC. Decreased seizure
threshold is often associated with increased neuronal
excitability. However, we did not observe any change in
intrinsic neuronal excitability of either hippocampal CA1
pyramidal neurons or cortical L5 pyramidal neurons in
MLC mice that could explain the decreased seizure
threshold. We conclude that intrinsic hyperexcitability of
principal neurons is not the cause of seizures in MLC.
K1-sensitive electrode recordings revealed increased
peak [K1]o rises in hippocampal CA1 upon trains of
Schaffer collateral stimulation in MLC mice. This was
not attributed to increased synaptic strength, given that
fEPSP amplitudes were unchanged. When recording pop-
ulation responses to the same Schaffer collateral stimula-
tion in stratum pyramidale, we observed an increase in
CA1 pyramidal neuron population spiking, indicative of
increased network excitability. In line with this, it was
previously shown that modest rises in [K1]o increase hip-
pocampal population spiking while leaving levels of syn-
aptic transmission unaffected.42 Therefore, we conclude
that although intrinsic excitability of individual neurons
is unchanged, MLC mice show altered [K1]o dynamics
and increased network excitability.
How could loss of function of the astrocyte-specific
protein MLC1 lead to disturbed [K1]o dynamics and
seizures? It is well established that astrocytes are crucial
for [K1]o homeostasis.
13,14 Mathematical models show
that disturbing glial K1 uptake can lead to seizures,43
and dysfunctional astrocyte [K1]o homeostasis is impli-
cated in epilepsy.44 K1 homeostasis is tightly linked to
the homeostasis of other ions, and MLC1 and GlialCAM
colocalize and/or interact with several proteins involved
in ion and water homeostasis. This includes the dystro-
phin glycoprotein complex,5,45 Na1/K1-ATPase,46 the
swelling-sensitive cation channel, TRPV4,47 and the gap-
junction protein, connexin 43.20 MLC1 and GlialCAM
may therefore play a central role in organizing these
components necessary for astrocyte ion and water
homeostasis.
In the healthy brain, astrocytes counteract increases
in [K1]o during periods of high neuronal activity
through transporter-mediated K1 uptake48 and spatial
K1 buffering.14 This leads to astrocyte swelling and
depolarization, which can be counteracted by activation
of VRACs. We and others have previously shown that
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mutations in MLC1 or GLIALCAM lead to dysfunction
of astrocytic VRACs,8–10 resulting in chronic astrocyte
swelling. We previously hypothesized that this could limit
the K1 uptake capacity of astrocytes, thereby leading to
activity-dependent white matter vacuolization.8 In line
with this hypothesis, our study confirms that [K1]o is
disturbed in MLC. We show that this is accompanied by
network hyperexcitability and seizures. The fact that
MLC patients show a high occurrence of status epilepti-
cus fits in this framework, given that a disturbed uptake
of K1 likely hampers restoration of disturbed ion gra-
dients following a seizure.
MLC1 and GlialCAM share their localization in
astrocyte endfeet abutting blood vessels with inwardly
rectifying Kir4.1 K
1 channels and AQP4 water channels.
Both these proteins are necessary for [K1]o regulation
and have been linked to seizures. Kir4.1 is crucial for K
1
spatial buffering49–51 and for efflux of K1 from astro-
cytes following active transport.48 Astrocyte-specific
Kir4.1 conditional knockout results in reduced astrocyte
K1 uptake, disturbed clearance of [K1]o, white matter
vacuolization, ataxia, and stress-induced seizures,15,16
thereby resembling the MLC phenotype. However,
astrocyte-specific Kir4.1 knockout mice are much more
severely affected and die at 3 to 4 weeks of age.15 Dis-
turbed AQP4 in perivascular endfeet also leads to abnor-
mal [K1]o dynamics and a seizure phenotype,
18,52,53
although the mechanism by which AQP4 interacts with
Kir4.1 and impacts on [K
1]o is not fully understood.
Epilepsy was long thought to be primarily caused
by malfunction of neurons, but in the last decades many
studies have convincingly shown that alterations in astro-
cyte function play an important role in its pathogene-
sis.43,53 In line with this, our study demonstrates that
loss of function of the astrocyte-specific protein MLC1
leads to dysregulation of [K1]o, network hyperexcitability
and seizures. These results highlight the importance of
astrocytes for neuronal network functioning and form an
important next step in our understanding of the cellular
pathophysiology of MLC.
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